Meeting Banner
Abstract #0812

Establishment of Patient-Derived Models of Renal Cell Carcinoma to Study Metabolism and Develop Relevant Clinical Biomarkers

Renuka Sriram1, Kayvan R. Keshari1, Mark Van Criekinge1, John Kurhanewicz1, David M. Wilson1, Donna M. Peehl2, Zhen J. Wang1

1University of California, San Francisco, San Francisco, CA, United States; 2Stanford University, Palo Alto, CA, United States

Renal cell carcinomas (RCCs) are a heterogeneous group of tumors with a wide range of aggressiveness. There is a current lack of noninvasive biomarkers that can confidently predict the behavior of RCCs to guide treatment selection and to monitor treatment response. Development of clinically relevant biomarkers of RCC aggressiveness and response to novel therapeutics requires robust models that recapitulate the human situation. The purpose of this study is to establish both an ex vivo and an in vivo model of RCCs using patient-derived tissue slices for metabolism studies in conjunction with hyperpolarized (HP) 13C MR.

Keywords

abnormally aggressiveness allows assay assays assess assessed audience blue bore broadband cancer cancers capsule carcinoma carcinomas cartridge cell cells clear clearly clinical clinically closely combined compatible compromised concept confidently confirms conjunction controlled culture currently custom dashed dead defense demonstrating derived described develop development diffusion disk dominant drawn dynamic efficient elevated enhance enhanced establish establishing experiment facilitate facilitates flux good grades graft grafts grants guide hours human identification immortalized in vivo indicating injection inset interrogation john kidney kinetics knockout lactate live living maintenance maximal measured metabolic metabolism metabolites mice microscopy mimics model models monitor mouse narrow noninvasive north novel nutrient optimal originate overlaid oxygen parametric patient perfusion phenotype phosphor planar plate post predict previously proliferation proton proximal pulses radiological reached relevant renal reported response robust rotating scholar selection since situation slice sliced slices specimens spectra stages staining suggests system target therapies therapy thick tissue tissues treatment tubule tumor tumors understanding unique unnaturally viability weeks